Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly
It is a great alternative to short term suppression
The stable gastric pentadecapeptide BPC 157 is a peptide that is always given alone, without any carrier, as a prototype of anti-ulcer cytoprotective peptide, native and stable in human gastric juice, used in clinical trial phase II (ulcerative colitis) and with a very safe profile (lethal dose LD1 not achieved) (for review, see [1,3,4,5,6,8,9,32,33,34])
Needle Compatibility Ensure that the needles you choose are compatible with the syringes and vials used for B12 injections
US$ 24.27
US$ 23.50
US$ 23.25
US$ 25.05
US$ 25.38
US$ 28.18
US$ 25.69
US$ 22.96